RSPH · Invesco S&P 500 Equal Weight Health Care ETF ETF
Invesco Exchange-Traded Fund Trust
$37.45
-1.11%
At close · Sep 4
Net assets $689,439,677
Holdings58
1 month
+5.37%
Year to date
+18.04%
52-week range
$28.26–$38.19
30-session avg volume
131,734
Market performance
Adjusted close · up to five years
Fund profile
- Structure
- Exchange-traded product
- SEC series
- S000060814
- Report date
- Apr 30, 2026
- Holdings coverage
- Tracked U.S. equities
Portfolio concentration
Top 10 holdings—
Calculated only when the SEC filing is stored with complete portfolio coverage.
Portfolio holdings
Latest linked SEC Form NPORT-P report.
| Holding | Ticker / CUSIP | Value | Weight |
|---|---|---|---|
| Centene Corp. | CNC | $18,349,631 | 2.66% |
| Humana Inc. | HUM | $16,945,655 | 2.46% |
| UnitedHealth Group Inc. | UNH | $15,915,821 | 2.31% |
| Elevance Health, Inc. | ELV | $15,912,779 | 2.31% |
| West Pharmaceutical Services, Inc. | WST | $15,302,971 | 2.22% |
| Cigna Group (The) | CI | $13,646,799 | 1.98% |
| CVS Health Corp. | CVS | $13,481,236 | 1.96% |
| Viatris Inc. | VTRS | $13,106,190 | 1.90% |
| Mettler-Toledo International Inc. | MTD | $12,752,057 | 1.85% |
| Waters Corp. | WAT | $12,738,421 | 1.85% |
| Bio-Techne Corp. | TECH | $12,645,156 | 1.83% |
| Bristol-Myers Squibb Co. | BMY | $12,379,688 | 1.80% |
| Align Technology, Inc. | ALGN | $12,338,301 | 1.79% |
| Incyte Corp. | INCY | $12,334,226 | 1.79% |
| DaVita Inc. | DVA | $12,280,262 | 1.78% |
| Agilent Technologies, Inc. | A | $12,267,712 | 1.78% |
| Solventum Corp. | SOLV | $12,207,451 | 1.77% |
| Biogen Inc. | BIIB | $12,180,357 | 1.77% |
| Charles River Laboratories International, Inc. | CRL | $12,113,840 | 1.76% |
| Edwards Lifesciences Corp. | EW | $12,027,674 | 1.74% |
| Steris PLC | STE | $12,000,187 | 1.74% |
| Pfizer Inc. | PFE | $11,986,538 | 1.74% |
| Henry Schein, Inc. | HSIC | $11,950,884 | 1.73% |
| Baxter International Inc. | BAX | $11,936,609 | 1.73% |
| Quest Diagnostics Inc. | DGX | $11,865,620 | 1.72% |
| Revvity, Inc. | RVTY | $11,844,419 | 1.72% |
| Thermo Fisher Scientific Inc. | TMO | $11,838,454 | 1.72% |
| Zoetis Inc. | ZTS | $11,762,236 | 1.71% |
| Labcorp Holdings Inc. | LH | $11,637,662 | 1.69% |
| Johnson & Johnson | JNJ | $11,594,553 | 1.68% |
| Merck & Co., Inc. | MRK | $11,515,761 | 1.67% |
| Eli Lilly and Co. | LLY | $11,472,215 | 1.66% |
| IDEXX Laboratories, Inc. | IDXX | $11,444,806 | 1.66% |
| Intuitive Surgical, Inc. | ISRG | $11,377,557 | 1.65% |
| AbbVie Inc. | ABBV | $11,371,763 | 1.65% |
| IQVIA Holdings Inc. | IQV | $11,314,745 | 1.64% |
| Amgen Inc. | AMGN | $11,241,006 | 1.63% |
| Danaher Corp. | DHR | $11,240,207 | 1.63% |
| Becton, Dickinson and Co. | BDX | $11,194,394 | 1.62% |
| Regeneron Pharmaceuticals, Inc. | REGN | $11,184,982 | 1.62% |
| Stryker Corp. | SYK | $11,163,795 | 1.62% |
| Medtronic PLC | MDT | $11,151,998 | 1.62% |
| Universal Health Services, Inc. | UHS | $11,072,503 | 1.61% |
| DexCom, Inc. | DXCM | $11,006,746 | 1.60% |
| Gilead Sciences, Inc. | GILD | $10,982,448 | 1.59% |
| Cardinal Health, Inc. | CAH | $10,973,136 | 1.59% |
| ResMed Inc. | RMD | $10,915,214 | 1.58% |
| Cencora, Inc. | COR | $10,781,274 | 1.56% |
| Zimmer Biomet Holdings, Inc. | ZBH | $10,779,783 | 1.56% |
| McKesson Corp. | MCK | $10,685,642 | 1.55% |